Complex Interventional Cardiovascular Therapy - 2018

San Francisco, CA
JULY 27-28, 2018


Target Audience

CICT 2018 has been designed to meet the educational needs of Interventional Cardiologists, Non-Invasive Cardiologists, Cardiology Fellows along with Cath Lab Nurses, Technicians, and other medical professionals who care for patients undergoing catheter-based cardiovascular interventions.

Educational Goal

The purpose of CICT 2018 symposium will be to provide a novel educational platform based on integration of patient-centered decision-making and the evidence-base in the field of Interventional Cardiovascular Medicine.

Learning Objectives

  • Demonstrate patient-centered evidence-based decision-making at the individual patient level
  • Acquire the skill set necessary to triage patients with complex coronary and structural heart disease to surgical vs. endovascular intervention
  • Learn cognitive and technical skills to maximize success and reduce complications in complex cardiovascular interventions
  • Identify best practices to prevent and manage complications in coronary and structural heart disease interventions

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Gaffney Events, LLC. The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The CMEsolutions designates this live activity for a maximum of 16.5 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participation Requirements

  1. Complete sign in sheet
  2. Attend accredited sessions
  3. For credit log on to URL: https://www.online-med-edu.com/cict/portal/2018/ (you are here)
  4. Complete evaluation, credit request form, and download or print credit statement

Faculty and Disclosures

CMEsolutions requires everyone in a position to control the content of this activity to disclose any relevant financial conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CMEsolutions for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Directors

Issam D. Moussa, MD, MBA, FACC, FSCAI
Director of Medicine, Clinical Director, Division of Cardiovascular Disease and Hypertension, Rutgers Robert Wood Johnson Medical School
New Brunswick, NJ
Issam D. Moussa has no relevant financial relationships to disclose.

Joseph De Gregorio, MD, FACC, FSCAI, FACP, FCCP 
Chief of Invasive Cardiology, Englewood Hospital & Medical Center
Englewood, NJ
Joseph De Gregorio has disclosed the following relevant financial relationships: Cardiva-Consultant , Advisory Board

Raj Makkar, MD, FACC
Director, Interventional Cardiology and Cardiac Cath Lab, Associate Director of Heart Institute for Interventional Technology, Cedars-Sinai Medical Center
Los Angeles, CA
Raj Makkar has disclosed the following relevant financial relationships:  Edwards Lifescience, Abbott, Claret Medical Inc., Medtronic – Consultant, Advisory Board

Co-Directors

Antonio Colombo, MD, FACC, MSCAI
Director, Cardiac Catheterization Laboratory EMO GVM Centro Cuore Columbus and San Raffaele Hospital
Milan, Italy
Antonio Colombo has no relevant financial relationships to disclose.

Ted Feldman, MD MSCAI, FACC, FESC
Director, Cardiac Catheterization Laboratory, NorthShore University HealthSystem Evanston Hospital
Evanston, IL
Ted Feldman has disclosed the following relevant financial relationships: Abbott, BSC, Edwards – Consultant, Advisory Board

Jonathan M. Tobis, MD, FACC, FSCAI
Professor of Medicine Director, Interventional Cardiology Research David Geffen School of Medicine, UCLA
Los Angeles, CA
Jonathan M. Tobis has no relevant financial relationships to disclose.

Faculty

Ali Vaqar, MD, FACC, FSCAI, FABVM
Vice President, First Coast Cardiovascular Institute, PA
Jacksonville, FL
Ali Vaqar has no relevant financial relationships to disclose.

Steven R. Bailey, MD, MSCAI, FACC, FACP
Professor of Medicine and Radiology, Chief, Division of Cardiology, Janey Briscoe Distinguished Chair
UT Health San Antonio
San Antonio, TX
Steven R. Bailey has no relevant financial relationships to disclose.

Malcolm R. Bell, MBBS, FRACP, FACC
Director, Ischemic Heart Disease Program; Professor of Medicine, Mayo Clinic College of Medicine; Consultant, Cardiovascular Diseases, Mayo Clinic
Rochester, MN
Malcolm R. Bell has no relevant financial relationships to disclose.

Maurice Buchbinder, MD, FACC, FSCAI
Medical Director, Structural Heart Services; Medical Director, Endovascular Services, San Diego Cardiovascular Associates Foundation for Cardiovascular Medicine
San Diego, CA
Maurice Buchbinder has no relevant financial relationships to disclose.

Tarun Chakravarty, MD
Interventional Cardiology, Smidt Heart Institute Cedars Sinai Medical Center
Los Angeles, CA
Tarun Chakravarty has disclosed the following relevant financial relationships: Edwards Lifescience, Medtronic – Consultant/Advisory Board

Ashok Chaudhary, MD
Assistant Professor, Structural Heart Disease, Interventional Cardiology Rutgers Robert Wood Johnson Medical School
New Brunswick, NJ
Ashok Chaudhary has no relevant financial relationships to disclose.

George Dangas, MD, PhD, FACC, FSCAI
Professor of Cardiology & Vascular Surgery, Director, Cardiovascular Innovation The Mount Sinai Hospital Icahn School of Medicine at Mount Sinai Hospital
New York, NY
George Dangas has disclosed the following relevant financial relationships: Boston Scientific-Consultant

Gary Gershony, MD
Director of CV Research, Education & Technology, John Muir Health and Cardiovascular Institute
Walnut Creek, CA
Gary Gershony has no relevant financial relationships to disclose.

Steven L. Goldberg, MD, FACC, FSCAI
Medical Director for Structural Heart Disease, Tyler Heart Institute at the Community
Hospital of the Monterey Peninsula (CHOMP)
Monterey, CA
Steven L. Goldberg has disclosed the following relevant financial relationships:  Cardiac Dimensions-Consultant

Cindy L. Grines, MD, FACC, FSCAI
Medical School Chair & Academic Chief, Cardiology, Hofstra Northwell School of Medicine,
North Shore University Hospital
Manhasset, NY
Cindy L. Grines has disclosed the following relevant financial relationships:  Abbott Vascular, Abiomed, Volcano-Consultant/Advisory Board

Rajiv Gulati, MD, PhD
Professor of Medicine, Mayo Clinic
Rochester, MN
Rajiv Gulati has no relevant financial relationships to disclose.

Abdul Hakeem, MD
Associate Professor of Medicine, Rutgers-Robert Wood Johnson Medical Center
New Brunswick, NJ
Abdul Hakeem has no relevant financial relationships to disclose.

Rajiv Jauhar, MD, FACC, FSCAI
Chief of Cardiology, Director of Cardiac Cath Labs, North Shore University Hospital Manhasset
Manhasset, NY
Rajiv Jauhar has no relevant financial relationships to disclose.

Amir K. Kaki, MD, FACC, FSCAI
Medical Director Cardiac Catheterization Laboratories, Assistant Professor of Medicine Detroit Medical Center Heart Hospital, Wayne State School of Medicine
Detroit, MI
Amir K. Kaki has disclosed the following relevant financial relationships: Abbott, Abiomed, CSI, Terumo Medical-Consultant/Advisory Board

Saibal Kar, MD
Director, Interventional Cardiac Research, Cedars Sinai Medical Center
Los Angeles, CA
Saibal Kar has disclosed the following relevant financial relationships: Edwards Lifescience-Research Support, Abbot Vascular, Boston Scientific-Consultant/Advisory Board

R. Stefan Kiesz, MD
Director of Interventional Cardiology, San Antonio Endovascular & Heart Institute
San Antonio, TX
R. Stefan Kiesz has no relevant financial relationships to disclose.

Michael C. Kim, MD, FACC, FSCAI
Director, Cardiac Cath Labs, Director, Interventional Cardiology Fellowship, Associate Professor of Cardiology, Hofstra North Shore-LIJ School of Medicine, Lenox Hill Heart and Vascular Institute
New York, NY
Michael C. Kim has no relevant financial relationships to disclose.

John M. Lasala, MD, PhD, FACC, FSCAI
Professor of Medicine, Washington University School of Medicine, Director, Structural Heart Program, Barnes-Jewish Hospital
St. Louis, MO
John M. Lasala has disclosed the following relevant financial relationships: Abiomed, Abbott St. Jude Medical, Astra Zeneca, Boston Scientific –Consultant/Advisory Board

Kiwon Lee, MD
Professor of Medicine, Robert Wood Johnson University Hospital
New Brunswick, NJ
Kiwon Lee has disclosed the following relevant financial relationships: BARD-Consultant/Advisory Board

Reginald Low, MD, FACC, FSCAI
Professor of Medicine, Chief, Division of Cardiovascular Medicine, University of California, Davis
Sacramento, CA
Reginald Low has disclosed the following relevant financial relationships: Abbot Vascular, Boston Scientific- Consultant/Advisory Board

Roxana Mehran, MD, FACC, FESC, MSCAI, FACP, FCCP, FAHA
Professor of Medicine (Cardiology) and Health Evidence and Policy, Director of Interventional Cardiovascular Research and Clinical Trials Unit, Icahn School of Medicine at Mount Sinai
New York, NY
Roxana Mehran has disclosed the following relevant financial relationships: Abbott Laboratories, Abiomed, BMS, Cardiovascular Systems Inc., Boston Scientific, Claret Medical Inc., Janssen Pharmaceuticals, Medscape, Siemens Medical Solutions, Spectranetics/Volcano/Philips, The Medicines Company- Consultant/Advisory Board; Astra Zeneca, Bayer, Beth Israel Deaconess Medical Center, CSL Behring, Eli Lilly/DSI, Novartis Pharmaceuticals, OrbusNeich, Watermark Research Partners-Funding to the Institution; Claret Medical Inc., Elixir Medical Corp.-Stocks

John C. Messenger, MD, FACC, FSCAI
Associate Professor, Director, Cardiac Catheterization Labs; Director, Cardiovascular ICU/Stepdown Unit; Program Director, Interventional Cardiology Fellowship Program, University of Colorado Hospital, University of Colorado Denver School of Medicine
Aurora, CO
John C. Messenger has no relevant financial relationships to disclose.

Ramon Quesada, MD, FACC, FSCAI, FACP
Medical Director, Interventional Cardiology, Research & Structural Heart Program
Miami Cardiac & Vascular Institute
Miami, FL
Ramon Quesada has no relevant financial relationships to disclose.

Bernhard Reimers, MD
Unit Director, Clinical and Invasive Cardiology, Humanitas Research Hospital
Milan, Italy
Bernhard Reimers has disclosed the following relevant financial relationships: BSCI, Terumo-Research Support

Jorge F. Saucedo, MD, MBA, FACC, FSCAI
Division Head, Cardiology, NorthShore University HealthSystem
Evanston, IL
Jorge F. Saucedo has no relevant financial relationships to disclose.

Richard A. Shlofmitz, MD, FACC, FSCAI
Chairman, Department of Cardiology, St. Francis Hospital, The Heart Center
Roslyn, NY
Richard A. Shlofmitz has disclosed the following relevant financial relationships: CSI-Speaker

Varinder P. Singh, MD, FACC, FSCAI
Chairman, Cardiovascular Medicine, Northwell Health Lenox Hill Heart and Vascular Institute
New York, NY
Varinder P. Singh has no relevant financial relationships to disclose.

Paul Teirstein, MD, FACC, FSCAI
Chief of Cardiology, Director of Interventional Cardiology, Scripps Clinic
La Jolla, CA
Paul Teirstein has disclosed the following relevant financial relationships: Abbott, Boston Scientific, Medtronic-Consultant/Advisory Board

Jennifer A. Tremmel, MD, MS, FACC, FSCAI
Assistant Professor of Medicine, Cardiovascular, Clinical Director of Women’s Heart Health
Standard University Medical Center
Stanford, CA
Jennifer A. Tremmel has disclosed the following relevant financial relationships: Terumo Medical, Medtronic, Boston Scientific, Abbott-Consultant; Recor-Stock

Thomas M. Tu, MD, FACC, FSCAI
Director, Cath Lab, Baptist Health Louisville
Louisville, KY
Thomas M. Tu has no relevant financial relationships to disclose.

Ron Waksman, MD, FACC, FSCAI
Director, Cardiovascular Research and Advanced Education, Professor of Cardiology,  Georgetown University, Associate Director, Division of Cardiology, Medstar Heart Institute
Washington, DC
Ron Waksman has disclosed the following relevant financial relationships: Abbott, Amgen, Biosensors, Biotronik, Boston Scientific, Cardioset, Philips Volcano, Medtronic, Pi-Cardia LTD-Consultant/Advisory Board; MedAlliance-Stock

Giora Weisz, MD
Associate Professor of Clinical Medicine, Columbia University, Director of Clinical Cardiovascular, Research, New York-Presbyterian Hospital, Columbia University Medical Center
New York, NY
Giora Weisz has Corindus, Filterlex -Consultant/Advisory Board; TriSol-Consultant

Ramzan M. Zakir, MD FACC, FSCAI
Clinical Assistant Professor of Medicine, Rutgers Medical School, Robert Wood Johnson University Hospital, Director of Peripheral Vascular Program, Saint Peters University Hospital
New Brunswick, NJ
Ramzan M. Zakir has disclosed the following relevant financial relationships: Abbot Vascular,
Boston Scientific, Cook Medical, Spectranetics/Volcano/Philips, CSI, Terumo Medical-Consultant/Advisory Board

Planner Disclosure

No member of CMEsolutions or Gaffney Events, LLC. has any relevant financial relationships to disclose.

Fees

The registration fee for this CME activity is $475.00 for physicians and $375.00 for Residents, Nurses and Technicians. Registration Fees are waived for Fellows in Training. The registration fee for Industry Personnel is $450.00.

Off-label Use

CICT 2018 may contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA.  Please consult the prescribing information for each product.

Commercial Support

Cook Medical
EKOS Corporation
Medtronic Cardiac and Vascular Group
Chiesi USA, Inc.          
Abbott Laboratories
Philips Image Guided Devices           
Terumo Interventional Systems

Privacy Policy

CMEsolutions Privacy and Confidentiality Policy: www.online-med-edu.com/privacypolicy.pdf
CMEsolutions can be contacted at info@cmesolutions.org.


 complete evaluation/credit request